Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05006378 · ClinicalTrials.gov registry record · NA
Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05006378: Completed NA study, sponsored by Stony Brook University.
NCT05006378 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05006378, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.
Interventions
- DIETARY_SUPPLEMENT Placebo Capsule
- DIETARY_SUPPLEMENT Chamomile Tea
- DIETARY_SUPPLEMENT Chamomile Extract Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2022-01-19 |
| Phase | NA |
What the finished NCT05006378 record still lists
NCT05006378 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo Capsule is the first listed.
NCT05006378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05006378 about?
NCT05006378 is a clinical study titled "Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers". Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.
What is the current status of trial NCT05006378?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-08-31. Estimated completion is 2022-01-19.
What interventions are being tested in trial NCT05006378?
The interventions under investigation include: Placebo Capsule (DIETARY_SUPPLEMENT), Chamomile Tea (DIETARY_SUPPLEMENT), Chamomile Extract Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05006378?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05006378's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI